Year archive

Onconic Therapeutics Inc. — 2024 filings

All 18 regulatory filings released by Onconic Therapeutics Inc. (476060) in 2024, sourced directly from the official regulator.

18 Filings

2024 Period

2024 filings (18)

Filing	Released	Lang
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-12-27	Korean
투자판단관련주요경영사항 (파트너사인 Livzon Pharmaceutical Group Inc.의 Zastaprazan(자큐보정) 중국 임상3상 시험 첫 환자 투여에 따른 마일스톤 기술료 청구 ) Regulatory Filings	2024-12-23	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-12-23	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Major Shareholding Notification	2024-12-23	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-12-23	Korean
[기재정정]주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-12-23	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-12-20	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-12-20	Korean
[기재정정]증권발행실적보고서 Share Issue/Capital Change	2024-12-13	Korean
증권발행실적보고서 Share Issue/Capital Change	2024-12-12	Korean
[발행조건확정]증권신고서(지분증권) Capital/Financing Update	2024-12-05	Korean
[기재정정]투자설명서 Capital/Financing Update	2024-12-05	Korean
투자설명서 Capital/Financing Update	2024-12-02	Korean
[기재정정]증권신고서(지분증권) Capital/Financing Update	2024-11-28	Korean
[기재정정]증권신고서(지분증권) Capital/Financing Update	2024-11-22	Korean
[기재정정]증권신고서(지분증권) Capital/Financing Update	2024-11-08	Korean
[첨부추가]증권신고서(지분증권) Share Issue/Capital Change	2024-10-16	Korean
감사보고서 (2023.12) Audit Report / Information FY 2023	2024-04-08	Korean